NCT04964518View on ClinicalTrials.gov

A Study of APG-2575 in Combination With Azacitidine in Patients With Acute Myeloid Leukemia (AML)

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

July 30, 2021

Primary Completion Date

July 30, 2024

Study Completion Date

October 30, 2024

Conditions
AML, Adult
Interventions
DRUG

APG 2575 ramp up arm

APG2575 ramp up + Azacitidine

Trial Locations (9)

3076

RECRUITING

The Northern Hospital, Epping

4217

RECRUITING

Pindara Private Hospital, Benowa

4575

RECRUITING

Sunshine Coast University Hospital, Birtinya

6000

RECRUITING

Royal Perth Hospital, Perth

27103

RECRUITING

Novant Health, Winston-Salem

28413

RECRUITING

Novant Health, Charlotte

77030

RECRUITING

MDACC, Houston

94101

RECRUITING

UCLA Medical cetner Division of Hematology, Los Angeles

98104

RECRUITING

Swedish Medical Center, Seattle

Sponsors
All Listed Sponsors
lead

Ascentage Pharma Group Inc.

INDUSTRY